Microbubble: A potential ultrasound tool in molecular imaging

Current Pharmaceutical Biotechnology

Volumn 9, Issue 5, 2008, Pages 406-410

  Patel, Rajesh M ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

Microbubble; Molecular imaging; Ultrasound contrast agent

Indexed keywords

ADENOVIRUS VECTOR; ALBUMIN; ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; ECHO CONTRAST MEDIUM; PERFLUTREN; PLASMID DNA; PROTEIN P53; CONTRAST MEDIUM;

BLOOD VESSEL OCCLUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; DRUG DELIVERY SYSTEM; ECHOGRAPHY; EMULSION; ENCAPSULATION; GAS DIFFUSION; GAS EMBOLISM; GENE THERAPY; GENETIC TRANSFECTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE THROMBOSIS; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; MATERIAL STATE; MICROBUBBLE; MICROBUBBLE INSTABILITY; MOLECULAR IMAGING; NONVIRAL GENE DELIVERY SYSTEM; PATHOPHYSIOLOGY; PLASMID; REVIEW; SENSITIVITY AND SPECIFICITY; SHAPE DEFORMATION; VIRAL GENE DELIVERY SYSTEM; CHEMISTRY; GENETIC PROCEDURES; IMAGE ENHANCEMENT; METHODOLOGY;

CONTRAST MEDIA; IMAGE ENHANCEMENT; MICROBUBBLES; MOLECULAR PROBE TECHNIQUES; ULTRASONOGRAPHY;

EID: 58149286290     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920108785915175     Document Type: Review

References (54)

1. Frenkel, P.A.; Chen, S.; Thai, T.; Shohet, R.V. and Grayburn, P.A. (2002) DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol., 28, 817-822.
2. Klibanov, L. (1999) Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv. Drug Deliv. Rev., 37, 139-157.
3. Lindner, J.R. and Kaul, S. (2001) Delivery of drugs with ultrasound, Echocardiography. J. Card. 18, 329-337.
4. Unger, E.C.; Matsunaga, T.O.; Mccreery, T.; Schumann, P.; Sweitzer, R. and Quigley R. (2002) Therapeutic applications of microbubbles. Eur. J. Radiol., 42, 160-168.
5. Skyba, D.M.; Price, R.J.; Linka, A.Z.; Skalak, T.C. and Kaul, S. (1998) Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation, 98, 290-293.
6. Chen, S.; Shohet, R.V.; Bekeredjian, R.; Frenkel, P. and Grayburn, P.A. (2003) Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targetedmicrobubble destruction. J. Am. Coll. Cardiol., 42, 301-08.
7. Shohet, R.V.; Chen, S.; Zhou, Y.T.; Wang, Z.; Meidell R.S. and Unger, R.H. (2000) Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation, 101, 2554-2556.
8. Mukherjee, D.; Wong, J.; Griffin, B.; Ellis, S.G.; Porter, T. and Sen, S. (2000) Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J. Am. Coll. Cardiol., 35, 1678-1686.
9. Villanueva, F.S.; Jankowski, R.J.; Manaughm, C. and Wagner, W.R. (1997) Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography. J. Am. Coll. Cardiol., 30, 689-693.
10. Miller, M.W. (2000) Gene transfection and drug delivery. Ultrasound Med. Biol., 26(1), 559-562.
11. Chomas, J.E.; Dayton, P., May, D. and Ferrara, K. (2001) Threshold of fragmentation for ultrasonic contrast agents. J. Biomed. Opt., 6, 141-150.
12. Song, J.; Chappell, J.C.; Qi, M.; Vangieson, E.J.; Kaul, S. and Price, R.J. (2002) Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J. Am. Coll. Cardiol., 39, 726-731.
13. Deng, C.X.; Sieling, F.; Pan, H. and Cui, J. (2004) Ultrasound-induced cell membrane porosity. Ultrasound Med. Biol., 30, 519-526.
14. Porter Tr.; Hiser, W.L.; Kricsfeld, D.; Deligonui, U.; Xie, F. and Iversen, P. (2001) Inhibition of carotid artery neointimal formation with intravenous microbubbles. Ultrasound Med. Biol., 27, 259-265.
15. Porter, T.R.; Knnap, D.; Venneri, L.; Oberdorfer, J.; Lof, J. and Iversen, P. (2003) Increased suppression of intracoronary c-myc protein synthesis within the stent or balloon injury site using an intravenous microbubble delivery system containing antisense to c-myc: comparison with direct intracoronary injection. J. Am. Coll. Cardiol., 41, 431.
16. Verma, I.M. and Somia, N. (1997) Gene therapy-promises, problems and prospects. Nature, 389, 239-242.
17. Epstein, P.S. and Plesset, M.S. (1950) On the stability of gas bubbles in liquid-gas solutions. J. Chem. Phys., 18, 1505-1509.
18. Forgacs, G.; Foty, R.A.; Shafrir, Y. and Steinberg, M.S. (1998) Viscoelastic properties of living embryonic tissue: a quantitative study. J. Biophys., 74, 2227-2234.
19. Fung, Y.C. (1993) Biomechanics: Mechanical Properties of living tissue, Springer-Verlag, New York.
20. Fyrillas, M.M. and Szeri, A.J. (1995) Dissolution or growth of soluble spherical oscillating bubbles: the effect of surfactants. J. Fluid. Mech., 289, 295-314.
21. Fyrillas, M.M. and Szeri, A. (1996) Surfactant dynamics and rectified diffusion of microbubbles. J. Fluid. Mech., 311, 361-378.
22. Halpern, D.; Jensen, O.E. and Grotberg, J.B. (1998) A theoretical study of surfactant and liquid delivery into the lung. J. Appl. Physiol., 85, 333-352.
23. Wei, K.; Jayaweera, A.R.; Firoozan, S.; Linka, A.; Skyba, D.M. and Kaul S. (1998) Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation, 97, 473-483.
24. Wu, Y.Q.; Unger, E.C.; Mccreery, T.P.; Sweitzer, R.H.; Shen, D.K. and Wu, G.L. (1998) Binding and lysing of blood clots using MRX-408. Invest. Radiol., 33, 880-885.
25. Thurston, G.B. (1972) The viscoelasticity of human blood. J. Biophys., 12, 1205-1217.
26. Thurston, G.B. (1996) "Viscoelastic properties of blood and blood analogs" in Advanced in hemodynamics and hemorheology, (Howe, T.G., Ed.), JAI Press, pp. 1-30.
27. Vawter, L.; Fung, Y.C. and West J.B. (1979) Constitutive equation of lung tissue elasticity. J. Biomech. Eng. Trans., 102, 85-90.
28. Blomley, M.J.; Albrecht, T.; Cosgrove, D.O.; Eckersley, R.J.; Butler-Barnes, J. and Jayaram, V. (1999) Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol., 25, 1341-1352.
29. Forsber, G.F.; Goldberg, B.B.; Liu, J.B.; Merton, D.A.; Rawool, N.M. and Shi, W.T. (1999) Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology, 210, 125-132.
30. Harvey, C.J.; Blomley, M.J.; Eckersley, R.J.; Heckemann, R.A.; Butler-Barnes, J. and Cosgrove, D.O. (2000) Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet, 355, 807-808.
31. Blomley, M.J.; Albrecht, T.; Cosgrove, D.O.; Patel, N.; Jayaram, V. and Butler-Barnes, J. (1999) Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SHU 508A: Early experience. Radiology, 210, 409-416.
32. Harvey, C.J.; Blomley, M.J.K.; Eckersley, R.J.; Heckemann, R.A.; Butler-Barnes, J. and Cosgrove, D.O. (1999) Improved detection of hepatic malignancies using pulse inversion mode of the ultrasound contrast agent Levovist (SH U 508A) early experience. Radiology, in press.
33. Albrecht, T.; Hoffmann, C.W.; Schmitz, S.A.; Schettler, S.; Overberg, A. and Germer, C.T. (2001) Phase inversion sonography during the liver-specific phase of Levovist: Improved detection of liver metastases. Am. J. Roentgenol., 176, 1191-1198.
34. Blomley, M.J.K.; Albrecht, T.; Wilson, S.R.; Burns, P.N.; Lafortune, M. and Leen, E. (1999) Improved detection of metastatic liver lesions using pulse inversion harmonic imaging with Levovist: a multicenter study. Radiology, 213, 1685.
35. Albrecht, T.; Blomley, M.J.K. and Cosgrove, D.O. (1999) Non-invasive diagnosis of hepatic cirrhosis by transit time analysis of an ultrasound contrast agent. Lancet, 353, 1579-1583.
36. Blomley, M.J.; Albrecht, T.; Cosgrove, D.O.; Jayaram, V.; Eckersley, R.J. and Patel, N. (1998) Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: Early experience in seven patients with metastases. Radiology, 209, 862-866.
37. Mulvagh, S.L.; Demaria, A.N.; Feinstein, S.B.; Burns, P.N.; Kaul, S. and Miller, J.G. (2000) Contrast echocardiography: current and future applications. J. Am. Soc. Echocardiogr., 13, 331-342.
38. Cohen, J.L.; Cheirif, J.; Segar, D.S.; Gillam, L.D.; Gottdiener, J.S. and Hausnerov, A.E. (1998) Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III multicentre trial. J. Am. Coll. Cardiol., 32, 746-752.
39. Cheng, S.C.; Dy, T.C. and Feinstein, S.B. (1998) Contrast echocardiography: Review and future directions. Am. J. Cardiol., 81(12), 41-80.
40. Skyba, D.M.; Price, R.J.; Linka, A.Z.; Skalak, T.C. and Kaul, S. (1998) Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation, 98, 290-293.
41. Price, R.J.; Skyba, D.M.; Kaul, S. and Skalak, T.C. (1998) Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation, 98, 1264-1267.
42. Porter, T.R.; Iversen, P.L.; Li, S. and Xie, F.(1996) Interaction of diagnostic ultrasound with synthetic oligonucleotide labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles, J. Ultrasound Med., 15, 577-584.
43. Main, M.L. and Grayburn, P.A. (1999) Clinical applications of transpulmonary contrast echocardiography. Am. Heart J., 137, 144-153.
44. Wei, K.; Skyba, D.M.; Firschke, C.; Jayaweera, A.R.; Lindner, J.R. and Kaul, S. (1997) Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J. Am. Coll. Cardiol., 29, 1081-1088.
45. Unger, E.C.; Mccreery, T.P.; Sweitzer, R.H.; Caldwell, V.E. and Wu, Y. (1998) Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent. Invest. Radiol., 33, 886-892.
46. Wu, Y.; Unger, E.C.; Mccreery, T.P.; Sweitzer, R.H.; Shen, D. and Wu, G. (1998) Binding and lysing of blood clots using MRX-408. Invest. Radiol., 33, 880-885.
47. Verma, I.M. and Somia, N. (1998) Gene therapy-promises, problems and prospects. Nature, 389, 239-242.
48. Newman, K.D.; Dunn, P.F.; Owens, J.W.; Schulick, A.H.; Virmani, R. and Sukhova, G. (1995) Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J. Clin. Invest., 96, 2955-2965.
49. Felgner, P.L. (1997) Nonviral strategies for gene therapy. Sci. Am. 276, 102-106.
50. Bao, S.; Thrall B.D. and Miller, D.L. (1997) Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol., 23, 953-959.
51. Porter, T.R.; Iversen, P.L.; Li, S. And Xie, F. (1996) Interaction of diagnostic ultrasound with synthetic oligonucleotide labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J. Ultrasound Med., 15, 577-584.
52. Taniyama, Y.; Tachibana, K.; Hiraoka, K.; Namba, T.; Yamasaki, K. and Hashiya, N. (2002) Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation, 105, 1233-1239.
53. Chen, S.; Shohet, R.V.; Bekeredjian, R.; Frenkel, P. and Grayburn, P.A. (2003) Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targetedmicrobubble destruction. J. Am. Coll. Cardiol., 42, 301-308.
54. Shohet, R.V.; Chen, S.; Zhou, Y.T.; Wang, Z.; Meidell, R.S. and Unger, R.H. (2000) Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation. 101, 2554-2556.